Thanks for the Golden Egg, Goose, But Don't Let the Door Hit You on Your Way Out | GenomeWeb

From the Wall Street Journal, here's a story that highlights the dramatic changes going on in the depths of big pharma. The feature article looks in particular at Pfizer and a round of layoffs it announced earlier this year -- among the 2,100 people cut was the inventor of Lipitor, "the bestselling pharmaceutical drug ever," according to the story.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.